New York, NY -- (ReleaseWire) -- 10/22/2012 --TagLikeMe Corp. (PINK:TAGG) traded in the range of $0.11 and $0.13 during its latest trading session. The stock had opened at $0.11 and closed at $0.13, up 12.96 percent from its previous close of $0.11. TagLikeMe recorded the volume of 13.478 million shares. Its average daily trading volume stands at 11.487 million shares. The company stock has traded in the range of $0.00 and $0.28 during its past 52 weeks.

TagLikeMe announced that it has started the development process for its app version for Windows 8 Surface tablets. The company also recently added Facebook access to its new site.

Find out how this announcement could affect TAGG by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=TAGG

PacWest Equities Inc. (PINK:PWEI) traded in the range of $0.25 and $0.45 during its latest trading session. The stock had opened at $0.39 and closed at $0.41, up 3.82 percent from its previous close of $0.39. PacWest Equities recorded the volume of 5.45 million shares. Its average daily trading volume stands at 6.61 million shares.

PacWest Equities reported the completion of acquisition of PurGro Electronics LLC. The company has $15 million in annual sales. PacWest Equities also recently entered organic food production market. The company is based out of Las Vegas in Nevada and it was formed in 1971.

Find out if PWEI could maintain the momentum by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=PWEI

Applied DNA Sciences Inc. (OTC:APDN) traded in the range of $0.20 and $0.24 during its latest trading session. The stock had opened at $0.21 and closed at $0.23, up 14 percent from its previous close of $0.20. Applied DNA Sciences recorded the volume of 6.434 million shares. Its average daily trading volume stands at 2.891 million shares. The company stock has traded in the range of $0.02 and $0.30 during its past 52 weeks.

Applied DNA Sciences is involved in the business of providing DNA based authentication and security solutions. The company is mainly operational in the United States and Europe.

Find out where APDN could be heading by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=APDN

OncoSec Medical Incorporated (OTC:ONCS) traded in the range of $0.42 and $0.49 during its latest trading session. The stock had opened at $0.42 and closed at $0.45, up 6.14 percent from its previous close of $0.43. OncoSec Medical recorded the volume of 2.704 million shares. Its average daily trading volume stands at 1.141 million shares. The company stock has traded in the range of $0.12 and $1.00 during its past 52 weeks.

OncoSec Medical reported that it has received CE mark for its electroporation device. The company is currently involved in the development of advanced stage ImmunoPulse DNA based immunotherapy.

Find out more about ONCS by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=ONCS

About WallStreetReport.net
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetReport.net

Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetBarron.com website, for complete risks and disclosures.

Contact Info:
WALL STREET REPORT
info@WallStreetReport.net
347-905-5009